Safety and Efficacy of Intravenous Immune Globulin in Treating Spinocerebellar Ataxia

NCT01350440 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

5

Enrollment

OTHER

Sponsor class

Conditions

Spinocerebellar Ataxia

Interventions

BIOLOGICAL: IVIG

Sponsor

University of South Florida

Collaborators

[object Object]